You are here

P&T News

September 23

Another facet of national opioid epidemic?
Treatment improves progression-free survival versus standard chemotherapy
Scientists demystify popular MS drug
Subcutaneous nanoparticles may help control autoimmune disorders

September 22

Sales staff downplayed drug’s addictive potential, court documents claim
Lantus gets the boot for diabetes
Participants could seek less-costly mix of patients, authors say
New study comes amid price-hike furor

September 21

Agency official overrules staff’s protests
Doctors dissatisfied with regulatory/paperwork burdens
Proposals are “unnecessary and ill-advised,” expert says
Once-daily canagliflozin/metformin combo lowers glucose
Anorectic drug is administered three times daily

September 20

DEA sees no medical use for tropical plant
System prevents patient-to-patient contamination
Sensor checks blood sugar every 15 minutes
Agency cites serious adverse events in dose-ranging trial

Pages